IRIS
SOLINAS, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.335
AS - Asia 2.771
EU - Europa 1.781
SA - Sud America 1.426
AF - Africa 89
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.416
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.249
BR - Brasile 1.257
SG - Singapore 1.104
CN - Cina 970
UA - Ucraina 700
DE - Germania 254
SE - Svezia 235
HK - Hong Kong 224
VN - Vietnam 174
IT - Italia 139
FI - Finlandia 110
FR - Francia 109
GB - Regno Unito 95
AR - Argentina 64
IN - India 49
TR - Turchia 39
BD - Bangladesh 35
RU - Federazione Russa 30
CA - Canada 29
IQ - Iraq 28
UZ - Uzbekistan 27
MX - Messico 25
VE - Venezuela 24
ZA - Sudafrica 24
JP - Giappone 21
EC - Ecuador 20
PK - Pakistan 20
BE - Belgio 19
CO - Colombia 19
MA - Marocco 19
CL - Cile 13
NL - Olanda 13
PL - Polonia 13
AU - Australia 11
DZ - Algeria 11
TN - Tunisia 11
ES - Italia 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
PE - Perù 9
ID - Indonesia 8
KE - Kenya 8
PY - Paraguay 8
RO - Romania 8
AZ - Azerbaigian 6
HN - Honduras 6
NP - Nepal 6
OM - Oman 6
PS - Palestinian Territory 6
UY - Uruguay 6
AT - Austria 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
IE - Irlanda 5
JO - Giordania 5
BG - Bulgaria 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
LT - Lituania 4
AL - Albania 3
AO - Angola 3
BW - Botswana 3
CR - Costa Rica 3
EG - Egitto 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PA - Panama 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
EU - Europa 2
HU - Ungheria 2
KR - Corea 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NI - Nicaragua 2
SD - Sudan 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CH - Svizzera 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MN - Mongolia 1
NO - Norvegia 1
PR - Porto Rico 1
QA - Qatar 1
Totale 10.411
Salva come PNG Salva come JPEG
Città #
Dallas 1.054
Chandler 630
Singapore 574
Jacksonville 420
San Jose 309
Hong Kong 224
Princeton 214
Ashburn 182
Nanjing 181
Dearborn 157
Beijing 126
São Paulo 106
Wilmington 105
Lauterbourg 93
Ann Arbor 67
Nanchang 67
Shanghai 65
Boardman 64
Ho Chi Minh City 63
Los Angeles 56
Santa Clara 42
Hanoi 41
Hebei 40
Shenyang 34
Woodbridge 34
Changsha 31
Tianjin 31
Andover 29
Brasília 29
Rio de Janeiro 29
Belo Horizonte 28
Jiaxing 26
Sassari 26
Buffalo 23
Tashkent 22
Hangzhou 21
Tokyo 21
Porto Alegre 19
Brussels 18
Kunming 17
Norwalk 17
Jinan 16
Johannesburg 15
New York 15
Curitiba 14
Baghdad 13
Toronto 13
Uberlândia 13
Campinas 12
Frankfurt am Main 12
Goiânia 12
Amsterdam 11
Chennai 11
Orem 11
Warsaw 11
Betim 10
Ribeirão Preto 10
Salvador 10
Atlanta 9
Caruaru 9
Caxias do Sul 9
Da Nang 9
Fortaleza 9
Nuremberg 9
Santo André 9
Sorocaba 9
Denver 8
Guarulhos 8
Haiphong 8
Marrùbiu 8
Medellín 8
Munich 8
Santiago 8
Seattle 8
São Bernardo do Campo 8
Auburn Hills 7
Brooklyn 7
Contagem 7
Council Bluffs 7
Duque de Caxias 7
Joinville 7
Lahore 7
London 7
Ningbo 7
Phoenix 7
Poplar 7
Quito 7
Recife 7
São José dos Pinhais 7
Aracaju 6
Asunción 6
Baku 6
Casablanca 6
Dhaka 6
Florianópolis 6
Franca 6
Guangzhou 6
Houston 6
João Pessoa 6
Juiz de Fora 6
Totale 5.852
Salva come PNG Salva come JPEG
Nome #
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 187
Acute hepatitis with bridging necrosis due to hydralazine intake. Report of a case 165
ARFI (acoustic radiation force impulse imaging) elastography in the liver fibrosis evaluation in HCV correlated chronic liver disease 156
CHANGES OF SERUM 2-5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS C 146
Skin Reaction in Antiviral therapy for Chronic Hepatitis C: A role for Polyethylene Glycol Interferon? 145
Autoimmunity in interferon treated patients with viral chronic liver disease of different etiologies 144
Alteration in thyrotropin (TSH), Prolactin (PRL) and Growth Hormone (GH) secretions in chronic alcoholism and in liver cirrhosis. 136
A 15 year old girl with fever, jaundice, haemolysis, and sudden clinical deterioration 135
Alterazioni degli indici di funzionalità tiroidea nelle epatopatie croniche. 135
Changes of serum 2-5 olygoadenylate synthetase during interferon treatmnet of chronic hepatitis C 134
A randomized controlled trial of interferon alpha-2b as therapy for chronic non-A, non-B hepatitis 131
ASSESSMENT OF VARICEAL PRESSURE WITH AN ENDOSCOPIC BALLOOON: EFFECTS OF PHARMACOLOGICAL THERAPY 131
Antibody to Hepatitis B Surface Antigen in chronic liver disease 130
Alpha-fetoprotein and Hepatitis B Virus infection in chronic liver disease 129
Autoantibodies and response to alpha interferon in patients with chronic viral hepatitis 126
Alanine amino-transferase, Alpha-fetoprotein, hepatocellular necrosis and regeneration in chronic liver disease 125
Aspetti di terapia delle epatiti croniche da virus B e non-A,non-B 124
CARRIER DETECTION AND EARLY DIAGNOSIS OF WILSON'S DISEASE BY RESTRICTION FRAGMENT LENGTH POLYMORPHISM ANALYSIS 123
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients 123
The role of pre-coreHBV mutants on the long-term outcome of chronic HBV hepatitis 123
SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model 123
Lichen planus associated with anti-liver-kidney mocrosome-positive chronic active hepatitis and hyperthyroidism 118
Patterns of respnse during therapy with interferon and outcome of of retreatment with interferon plus ribavirin 118
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas 118
Chronic liver disease, alcohol consumption and HBsAg antigen in Italy: a multi-regional control study 117
Interferon therapy for chronic hepatitis C 115
Course of patients coinfected with HIV and hepatotropic viruses 113
T lymphocyte subsets in parenteral and non-parenteral heroin abusers in Britain 113
The tumour microenvironment and immune milieu of cholangiocarcinoma 112
Changes of serum 2-5- olygoadenilate synthetase during interferon therapy in patients with chronic HCV hepatitis 111
Alanic transferase, Alphafetoprotein, hepatocellular necrosis and regeneration in chronic liver disease. 111
Aspetti della diagnostica delle infezioni croniche da virus dell'epatite B 111
Reazioni cutanee da farmaco: manifestazione eczema-like in corso di terapia antivirale per epatite da virus C 109
The problem of cancer diagnosis in thyroid nodules: a study in an endemic area for goiter in North Sardinia 108
Thymic hormones in the treatment of chronic HBV infection 107
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 107
Programmed death ligand 1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer? 106
Porto-hepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitits C virus infection 105
Cognitive dysfunction and hepatitis C virus infection 103
Espressione immunomorfologica e quadri sierologici dell'epatite da virus B 102
Effect of different doses (1,000,000 AND 3,000,000 units ) od interferon alfa on the ALT levels of nonAnonB patients 101
Lichen planus, chronic liver disease and immunologic involvement 100
PRE-CORE MUTANTS AND RESPONSIVENESS TO INTERFERON IN CHRONIC HEPATITIS B 100
Systemic amyloidosis rapidly progressing to liver failure and hepato-renal syndrome. Report of a case 99
Patterns of response during therapy with interferon and outcome of retreatment with interferon plus ribavirin 98
Systemic lupus erythematosus in a patient with chronic hepatitis C 96
Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. European Concerted Action on Viral Hepatitis (EUROHEP) 96
Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A, non-B hepatitis. A randomized controlled trial 95
The long lasting course of chronic hepatitis C infected patients treated with interferon alfa-2b 95
Impaired thyrotropin (TSH) response to thyrotropin releasing hormone (TRH) in hepatic encephalopathy 94
Growth hormone (GH) secretion in hepatic encephalopathy 94
Early diagnosis of Wilsonìs Disease by DNA analysis 93
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study 93
Twenty-four novel mutations in Wilson Disease of predomintaly Italian origin 92
M. paratuberculosis may cause Crohn’s disease 91
Pituitary secretion in hepatic encephalopathy 91
Epatite cronica in pazienti con coinfezione multipla HIV-Virus epatotropi 91
Impaired thyrotrophin (TSH) response to thyrotrophin releasing hormone (TRH) in hepatic encephalopathy 91
Identification of Mycobacterium avium subsp paratuberculosis in biopsy specimens from patients with Crohn\'s disease identified by in situ hybridization 90
Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection 90
Thyrotropin (TSH) and prolactin (PRL) responses to thyrotropin-releasing hormone (TRH) in chronic alcoholism (CA) and in liver cirrhosis (LC) 90
us-GUIDED DIRECT TRANS-HEPATIC MEASUREMENT OF THE VENOUS PORTAL GRADIENT: A NEW APPROACH TO EVALUATE PORTAL HYPERTENSION 89
LONG-TERM RESPONSE TO INTERFERON ALFA RE-TREATMENT IN CHRONIC HEPATITIS C 88
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the study of liver transplantation 87
Receptors for polymerized human serum albumin 87
High resolution-magic angle spinning (HR-MAS)-NMR based metabolomic fingerprints of early and recurrent hepatocellular carcinoma 87
tHE LONG-TERM VARICEAL PRESSURE RESPONSE TO NADOLOL ALONE AND NADOLOL PLUS ISOSORBIDE MONONITRATE 86
Identification of Mycobacterium avium subp. paratuberculosis in biopsies from patients with Crohn\'s disease identified by in situ hybridization 86
Occurrence of hepatocellular carcinoma and decompensation in Western patients with cirrhosis type B 85
HBsAg carrier and liver disease 85
Circulating immune complexes during acute viral hepatitis type B: an attempt to detect HBsAg as their antigenic component by means of direct immunofluorescence on Raji cells 84
MOLECULAR PATHOLOGY AND HAPLOTYPE ANALYSIS OF WILSON DISEASE IN MEDITERRANEAN POPULATIONS 84
Immune complexes and complement system in HBsAg positive liver diseases 83
Polymerase chain reaction assay for detection of Hepatitis B Virus DNA in the serum of HBsAg/antiHBe positive subjects 82
Enfermedad de Erdheim-Chester: reporte de 2 casos 81
TSH secretion in patients with hepatic encephalopathy 81
Free thyroid hormone concentration in chronic alcoholes with liver steatosis. M. Langer, S. Rassu, P.P. 81
Livelli sierici delle frazioni C3 e C4 del complemento in corso di epatopatia 80
Toxic epidermal necrolysis in a patient affected by mixed essential cryoglobulinemia 80
Interferon alpha therapy in sicilian and sardinan polytransfused thalassemic patients with chronic hepatitis C 80
Sex steroids and sex hormone binding globulin in males with chronic alcoholism and liver cirrhosis 80
Marcatori del virus dell'epatite B, stato della replicazione virale condizioni cliniche associate 78
Hepatic hemodynamics and liver function: comparison of a six month course of nadolol and octreotide 78
Imaging e valutazione emodinamica nella diagnostica epatologica. Emodinamica epatica invasiva 77
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alpha 2b 77
Hepatitis D Virus infection in parenteral drug abusers 76
Characterization of Hepatitis B Virus Core region DNA in circulating Dane particles using direct sequencing of single stranded template generated by asymmetric polymerase chain reaction 76
Free thyroid hormones and chronic liver disease 75
PROLONGED TREATMENT (2YEARS) WITH DIFFERENT DOSES (3 VS 6 MU) OF INTERFERON ALFA2B FOR CHRONIC HEPATITIS C 75
Recurrent Hepatitis Delta Virus infection after liver transplantation 74
The predictive value of free thyroid hormones in patients with liver cirrhosis 73
Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis 73
Correlazione tra aspetti istologici e valori sierici di alfafetoproteina in epatopatie croniche HBV positive. 73
Longitudinal study of anti-HBe and DNA polymerase positive patients with chronic liver disease 73
High resolution-magic angle spinning (HR-MAS) NMR-based metabolomic fingerprinting of early and recurrent hepatocellular carcinoma 72
Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary centres in Europe 71
Correlazione tra aspetti istologici e valori serici di AFP in epatopatie croniche HBV positive 70
Follow-up study of alpha-fetoprotein in chronic liver disease. Its role in the detection of primary hepatocellular carcinoma. 69
Il trattamento con levamisolo in corso di epatite cronica attiva 69
Growth hormone secretion in chrnic liver disease 68
Totale 10.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.223
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.223
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 0 0 0 0 0 0 26
2021/2022503 93 1 3 2 3 5 37 34 52 14 50 209
2022/20231.182 113 58 15 183 155 206 0 162 214 12 34 30
2023/2024180 66 21 5 10 23 1 0 9 0 0 9 36
2024/20252.595 24 15 175 43 119 57 206 524 950 334 85 63
2025/20263.371 91 907 328 503 230 312 450 164 188 117 69 12
Totale 10.439